Treatment-Stage Migration Maximizes Survival Outcomes In Patients With Hepatocellular Carcinoma Treated With Sorafenib: An Observational Study
LIVER CANCER(2017)
摘要
Background: Level I evidence supports the use of sorafenib in patients with Barcelona Clinic Liver Cancer (BCLC) stage C hepatocellular carcinoma, where heterogen
更多查看译文
关键词
Hepatocellular carcinoma,Sorafenib,Treatment stage migration,Prognosis,Treatment-naive patients
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要